Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$281,106
+$75,954 QoQ
Shares Held
2,225
+51.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,693
of 2,266 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Enterprise Financial Services Corp holds $12,653,618 across 10 Drug Manufacturers - General names. GILD ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,105 | $3,297,741 | |
| 2 | LLY |
ELI LILLY & Co
|
2,069 | $2,481,620 | |
| 3 | MRK |
Merck & Co., Inc.
|
18,619 | $2,392,541 | |
| 4 | JNJ |
Johnson & Johnson
|
8,275 | $2,101,601 | |
| 5 | PFE |
Pfizer Inc
|
24,377 | $586,998 | |
| 6 | AMGN |
Amgen Inc
|
1,281 | $463,875 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,683 | $442,694 | |
| 8 | NVS |
Novartis AG
|
2,081 | $326,133 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,106 | 2,225 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $205,152 | 1,472 | Shares | Defined | 2026-05-05 | |
| 2021-09-30 | $787,558 | 11,275 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $56,051 | 814 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $54,805 | 848 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $52,607 | 903 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $80,250 | 1,270 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $153,648 | 1,997 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $144,884 | 1,938 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||